Rejection of drug a blow for Australians living with Alzheimer’s disease
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 9:45 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
A new treatment for people living with the early stages of Alzheimer’s disease or mild cognitive impairment has been rejected by the Therapeutic Goods Administration (TGA).
With Dementia becoming the leading cause of death in Australia, it’s disappointing news for those impacted by Alzheimers.
Guest: Dr Kaele Stokes is Dementia Australia’s Executive Director – Services, Advocacy & Research.
Presenter: Warren Andrew.
Podcast: Play in new window | Download (Duration: 9:45 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
RECENT PODCAST
Leo Stubbing: New Music from Hilary Duff , Leigh-Anne and Lana Del Rey
Hilary Duff is back with her first album in a decade, Leigh-Anne steps out independently with her solo debut, and ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 14:57 — 20.5MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Laureate Professor Clare Collins: Coffee and Blood Pressure
Coffee can cause a short-term rise in blood pressure, yet large-scale research suggests it may not increase long-term hypertension risk ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 6:58 — 9.6MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Dr Jeremie Bracka: Victoria’s LGBTQIA+ Hate Crimes Inquiry
Victoria’s new inquiry into LGBTQIA+ hate crimes marks a significant moment for accountability and prevention. Dr Jeremie Bracka explains why ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 9:16 — 12.7MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS